Genomic Landscape and Clinical Features of Carcinomas with ERBB2 S310 Extracellular Domain Mutations

被引：0

作者：

Desmeules, Patrice ^{[1
]}

Zehir, Ahmet ^{[1
]}

Hyman, David M. ^{[1
]}

Arcila, Maria E. ^{[1
]}

Ladanyi, Marc ^{[1
]}

机构：

[1] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA

来源：

MODERN PATHOLOGY | 2017年 / 30卷

关键词：

D O I：

暂无

中图分类号：

R36 [病理学];

学科分类号：

100104 ;

摘要：

1831

引用

页码：456A / 456A

页数：1

共 50 条

[31] An application of ERBB2 receptor inhibitors in a rare case of S310F somatic ERBB2 mutation of primary signet-ring cell adenocarcinoma of vagina: A case report and review literature of S310F somatic ERBB2 mutation in breast and gynecologic cancers
Hou, June Y.
Wright, Jason D.
Achariyapota, Vuthinun
GYNECOLOGIC ONCOLOGY REPORTS, 2020, 32
[32] ERBB2 mutations associated with solid variant of high-grade invasive lobular breast carcinomas
Deniziaut, Gabrielle
Tille, Jean Christophe
Bidard, Francois-Clement
Vacher, Sophie
Schnitzler, Anne
Chemlali, Walid
Tremoulet, Laurence
Fuhrmann, Laetitia
Cottu, Paul
Rouzier, Roman
Bieche, Ivan
Vincent-Salomon, Anne
ONCOTARGET, 2016, 7 (45) : 73337 - 73346
[33] Genomic Landscape Analysis of ERBB3-mutated Human Cancers Reveals Common CoOccurrence with Activating ERBB2 Alterations
Odintsov, Igor
Somwar, Romel
Ladanyi, Marc
MODERN PATHOLOGY, 2022, 35 (SUPPL 2) : 1255 - 1255
[34] Crosstalk between the extracellular domain of the ErbB2 receptor and IGF-1 receptor signaling
Belaus, A
Merkle, C
Fritsche, M
Groner, B
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2003, 85 (2-5): : 105 - 115
[35] Genomic Landscape of ERBB2 Alterations in Solid Tumors without an Approved HER2-Targeted Therapy
Previs, R.
Ko, H.
Cooper, M.
Wallen, Z.
Nesline, M.
Pabla, S.
Hastings, S.
Strickland, K.
Zhang, S.
Sathyan, P.
Conroy, J.
Jensen, T.
Eisenberg, M.
Caveney, B.
Reddy, P.
Severson, E.
Ramkissoon, S.
JOURNAL OF MOLECULAR DIAGNOSTICS, 2023, 25 (11): : S132 - S132
[36] High Frequency of ERBB2 Activating Mutations in Invasive Lobular Breast Carcinoma with Pleomorphic Features
Manuel Rosa-Rosa, Juan
Caniego-Casas, Tamara
Leskela, Susanna
Cristobal, Eva
Gonzalez-Martinez, Silvia
Moreno-Moreno, Esther
Lopez-Miranda, Elena
Holgado, Esther
Perez-Mies, Belen
Garrido, Pilar
Palacios, Jose
CANCERS, 2019, 11 (01)
[37] Clinical and molecular characteristics of Chinese non-small cell lung cancer patients with ERBB2 transmembrane domain mutations
Fan, Yun
Qiu, Jinrong
Yu, Ruoying
Cao, Ran
Chen, Xiaoxi
Ou, Qiuxiang
Wu, Xue
Shao, Yang W.
Nagasaka, Misako
Zhang, Jiexia
Ou, Sai-Hong Ignatius
MOLECULAR ONCOLOGY, 2020, 14 (08) : 1731 - 1739
[38] A High Frequency of Activating Extracellular Domain ERBB2 (HER2) Mutation in Micropapillary Urothelial Carcinoma
Ross, Jeffrey S.
Wang, Kai
Gay, Laurie M.
Al-Rohil, Rami N.
Nazeer, Tipu
Sheehan, Christine E.
Jennings, Timothy A.
Otto, Geoff A.
Donahue, Amy
He, Jie
Palmer, Gary
Ali, Siraj
Nahas, Michelle
Young, Geneva
LaBrecque, Elaine
Frampton, Garrett
Erlich, Rachel
Curran, John A.
Brennan, Kristina
Downing, Sean R.
Yelensky, Roman
Lipson, Doron
Hawryluk, Matthew
Miller, Vincent A.
Stephens, Philip J.
CLINICAL CANCER RESEARCH, 2014, 20 (01) : 68 - 75
[39] Mutations in the Kinase Domain of the HER2/ERBB2 Gene Identified in a Wide Variety of Human Cancers
Wen, Wenhsiang
Chen, Wangjuh
Xiao, Nick
Bender, Ryan
Ghazalpour, Anatole
Tan, Zheng
Swensen, Jeffrey
Millis, Sherri Z.
Basu, Gargi
Gatalica, Zoran
Press, Michael F.
JOURNAL OF MOLECULAR DIAGNOSTICS, 2015, 17 (05): : 487 - 495
[40] Treatment of Metastatic Extramammary Paget's Disease Associated With Adnexal Adenocarcinoma, With Anti-HER2 Drugs Based on Genomic Alteration ERBB2 S310F
Vornicova, Olga
Hershkovitz, Dov
Yablonski-Peretz, Tamar
Ben-Itzhak, Ofer
Keidar, Zohar
Bar-Sela, Gil
ONCOLOGIST, 2014, 19 (09): : 1006 - 1007

← 1 2 3 4 5 →